OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
4102$1446.0057

Maruo Calcium Co Ltd

Commodity ChemicalsVerified

Maruo Calcium maintains a conservative capital structure with a debt-to-equity ratio of 0.24 and a current ratio of 2.64, indicating strong liquidity and short-term solvency. The company holds JPY 2.39 billion in cash and equivalents, which is 14.2% of total assets, and has a price-to-book ratio of 0.31, suggesting a significant discount to its book value. Profitability metrics are weak relative to industry norms. Return on equity (ROE) is 1.52% and return on assets (ROA) is 0.88%, both below the typical thresholds for Commodity Chemicals firms. Operating income of JPY 4.13 million in the latest period reflects a narrow margin, with gross profit at 16.8% of revenue. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. All operations are based in Japan, and the company does not report revenue by region, suggesting a high concentration risk in its domestic market. Growth appears stagnant, with no significant revenue or earnings growth reported in the latest financials. The company's free cash flow is negative at JPY -242.77 million, driven by capital expenditures of JPY -866.85 million, indicating reinvestment in operations rather than value creation. Risk factors are minimal in the short term, with low liquidity and dilution risk scores. No immediate filing-based flags were detected, and the company has not issued new shares in the past year. However, the low ROE and ROA suggest operational inefficiencies that could impact long-term stability. Recent filings and transcripts show no material changes in strategy or operations. The company continues to focus on its core calcium carbonate and inorganic chemical products, with no disclosed R&D initiatives or new market entries in the latest annual report.

30-day price · 4102(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyMaruo Calcium Co Ltd
Ticker4102.T
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Maruo Calcium Co., Ltd. is a Japan-based company engaged in the manufacture and sale of calcium carbonate and related inorganic chemicals, including talc and silica, primarily used in synthetic resins, paints, rubber, and food additives.

Classification. Maruo Calcium is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry with a confidence level of 0.92.

Maruo Calcium maintains a conservative capital structure with a debt-to-equity ratio of 0.24 and a current ratio of 2.64, indicating strong liquidity and short-term solvency. The company holds JPY 2.39 billion in cash and equivalents, which is 14.2% of total assets, and has a price-to-book ratio of 0.31, suggesting a significant discount to its book value. Profitability metrics are weak relative to industry norms. Return on equity (ROE) is 1.52% and return on assets (ROA) is 0.88%, both below the typical thresholds for Commodity Chemicals firms. Operating income of JPY 4.13 million in the latest period reflects a narrow margin, with gross profit at 16.8% of revenue. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. All operations are based in Japan, and the company does not report revenue by region, suggesting a high concentration risk in its domestic market. Growth appears stagnant, with no significant revenue or earnings growth reported in the latest financials. The company's free cash flow is negative at JPY -242.77 million, driven by capital expenditures of JPY -866.85 million, indicating reinvestment in operations rather than value creation. Risk factors are minimal in the short term, with low liquidity and dilution risk scores. No immediate filing-based flags were detected, and the company has not issued new shares in the past year. However, the low ROE and ROA suggest operational inefficiencies that could impact long-term stability. Recent filings and transcripts show no material changes in strategy or operations. The company continues to focus on its core calcium carbonate and inorganic chemical products, with no disclosed R&D initiatives or new market entries in the latest annual report.
Key takeaways
  • Maruo Calcium has a strong liquidity position with a current ratio of 2.64 and JPY 2.39 billion in cash.
  • Profitability is weak, with ROE and ROA below industry norms, and operating income at JPY 4.13 million.
  • The company's revenue is entirely concentrated in Japan, with no geographic diversification.
  • Free cash flow is negative due to high capital expenditures, indicating reinvestment rather than value creation.
  • No immediate liquidity or dilution risks are present, but operational inefficiencies could affect long-term performance.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyJPY
Revenue$12.84B
Gross profit$2.16B
Operating income$4.1M
Net income$148.6M
R&D
SG&A
D&A
SBC
Operating cash flow$246.9M
CapEx-$866.8M
Free cash flow-$242.8M
Total assets$16.87B
Total liabilities$7.07B
Total equity$9.80B
Cash & equivalents$2.39B
Long-term debt$2.31B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$12.84B$4.1M$148.6M-$242.8M
FY-1$12.89B$100.3M$249.2M$318.1M
FY-2$12.59B-$6.4M$117.1M-$164.6M
FY-3$11.57B$134.5M$190.8M$393.8M
FY-4$10.84B$150.1M$179.8M$448.4M
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$16.87B$9.80B$2.39B
FY-1$17.01B$9.62B$3.15B
FY-2$16.99B$9.30B$3.65B
FY-3$15.64B$8.90B$3.26B
FY-4$16.60B$9.43B$3.46B
PeriodOCFCapExFCFSBC
FY0$246.9M-$866.8M-$242.8M
FY-1$509.0M-$328.2M$318.1M
FY-2$464.8M-$691.6M-$164.6M
FY-3$529.3M-$327.5M$393.8M
FY-4$1.08B-$366.2M$448.4M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$3.25B$66.1M$90.8M
FQ-1$3.04B$15.1M$86.4M
FQ-2$2.99B-$36.5M$343.0k
FQ-3$2.98B-$45.2M$18.3M
FQ-4$3.39B$29.7M$61.8M
FQ-5$3.20B-$19.7M$9.7M
FQ-6$3.27B$39.3M$58.8M
FQ-7$3.14B-$82.9M-$25.9M
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$17.08B$10.04B$2.02B
FQ-1$16.83B$9.74B$2.36B
FQ-2$17.33B$9.73B$2.79B
FQ-3$16.87B$9.80B$2.39B
FQ-4$17.42B$9.64B$2.52B
FQ-5$18.53B$9.73B$4.81B
FQ-6$18.99B$9.66B$4.79B
FQ-7$17.01B$9.62B$3.15B
PeriodOCFCapExFCFSBC
FQ0
FQ-1$306.2M-$322.1M
FQ-2
FQ-3$246.9M-$866.8M
FQ-4
FQ-5$580.7M-$403.8M
FQ-6
FQ-7$509.0M-$328.2M
Valuation
Market price$1446.00
Market cap$3.08B
Enterprise value$3.00B
P/E20.8
Reported non-GAAP P/E
EV/Revenue0.2
EV/Op income726.3
EV/OCF12.2
P/B0.3
P/Tangible book0.3
Tangible book$9.80B
Net cash$82.6M
Current ratio2.6
Debt/Equity0.2
ROA0.9%
ROE1.5%
Cash conversion1.7%
CapEx/Revenue-6.8%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric4102Activity
Op margin0.0%0.4% medp25 -8.0% · p75 16.0%below median
Net margin1.2%2.3% medp25 -11.6% · p75 11.8%below median
Gross margin16.8%20.8% medp25 14.9% · p75 24.0%below median
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-6.8%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity24.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Observations
IR observations
Last actual EPS67.52 JPY
Last actual revenue12,843,000,000 JPY
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-04 00:51 UTC#88af23e3
Market quoteclose JPY 1446.00 · shares 0.00B diluted
no public URL
2026-05-04 00:51 UTC#f3bf7740
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 00:52 UTCJob: 85f46245